CB5712809, a novel Keap1 inhibitor upregulates SQSTM1/p62 mediated Nrf2 activation to induce cell death in colon cancer cells.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02787-7
- By:
- Publication type:
- Article
Works by Al Fayi, Majed
Results: 15
1
2
CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02574-4
- By:
- Publication type:
- Article
3
Thymoquinone inhibits IL‐7‐induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF‐κB signaling.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 6, p. 1403, doi. 10.1002/bab.2062
- By:
- Publication type:
- Article
4
FCX‐146, a potent allosteric inhibitor of Akt kinase in cancer cells: Lead optimization of the second‐generation arylidene indanone scaffold.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 1, p. 82, doi. 10.1002/bab.1896
- By:
- Publication type:
- Article
5
FPX-113 attenuates inflammatory responses by deteriorating cytokines, neutrophil activity and mast cell degranulation via Akt/ NF- κB pathway.
- Published in:
- Biologia, 2020, v. 75, n. 3, p. 447, doi. 10.2478/s11756-019-00367-z
- By:
- Publication type:
- Article
6
Computational docking and in vitro analysis identifies novel arylidene analogue FPMXY-14 against renal cancer cells by attenuating Akt.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 217, doi. 10.32604/or.2022.03570
- By:
- Publication type:
- Article
7
IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell.
- Published in:
- Oncology Research, 2020, v. 28, n. 2, p. 177, doi. 10.3727/096504019X15746768080428
- By:
- Publication type:
- Article
8
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 6, p. 655, doi. 10.1007/s12272-020-01241-2
- By:
- Publication type:
- Article
9
Molecular detection of urogenital mollicutes in patients with invasive malignant prostate tumor.
- Published in:
- Infectious Agents & Cancer, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13027-021-00344-9
- By:
- Publication type:
- Article
10
Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer.
- Published in:
- Current Issues in Molecular Biology, 2025, v. 47, n. 6, p. 463, doi. 10.3390/cimb47060463
- By:
- Publication type:
- Article
11
Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
- Published in:
- Journal of Drug Targeting, 2020, v. 28, n. 9, p. 913, doi. 10.1080/1061186X.2020.1722136
- By:
- Publication type:
- Article
12
FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
13
Clinicopathological features and prevalence of prostate cancer in Aseer, Saudi Arabia.
- Published in:
- Saudi Medical Journal, 2022, v. 43, n. 7, p. 755, doi. 10.15537/smj.2022.43.7.20210758
- By:
- Publication type:
- Article
14
Thymoquinone (Tq) protects necroptosis induced by autophagy/mitophagy‐dependent oxidative stress in human bronchial epithelial cells exposed to cigarette smoke extract (CSE).
- Published in:
- Journal of Food Biochemistry, 2020, v. 44, n. 9, p. 1, doi. 10.1111/jfbc.13366
- By:
- Publication type:
- Article
15
Anti-cancer effects of Nepeta Deflersiana Extract (NDE) in estrogen positive and negative forms of breast cancer.
- Published in:
- Pharmacognosy Magazine, 2021, v. 17, p. 287, doi. 10.4103/pm.pm_464_20
- By:
- Publication type:
- Article